Home / Intelligence / Blog

Search

Blog

Is Medical Omnichannel Poised for Growth?

Published December 10, 2024

79% of respondents are predicting an increase in spend in Omnichannel capabilities for Medical Affairs in 2025, according to a recent TGaS survey fielded in September 2024.* This predicted increase for Medical Omnichannel indicates that there is a real need to find ways to inform, educate and engage HCPs beyond the traditional in-person channel.    What is Medical Omnichannel?  Medical omnichannel is an orchestrated approach to scientific engagement, leveraging analytics and insights to optimize educational content and channels in a customer-centric…

Read Now

Blog

Key Takeaways and Learnings from HLTH 2024 

Published November 12, 2024

Trinity Life Sciences recently attended the HLTH 2024 conference in Las Vegas. The conference focused on “pushing boundaries to transform the next decade of health” and united stakeholders across the entire healthcare ecosystem, including life sciences professionals, providers, payers, government, healthcare policymakers, investors and more. Trinity’s Customer Engagement team participated in workshops and discussions to hear the latest from our peers, other industry leaders and sponsors – here are our key takeaways from HTLH 2024:  Moving from Multichannel to Omnichannel …

Read Now

Blog

Foundational Differentiation: CE Requires Efficient Operationalization of Data

Published November 5, 2024

What is data operationalization, and why is it important in life sciences? The ability to integrate insights from your data into your business workflows is commonly referred to as data operationalization. Throughout life sciences organizations, functional needs and behaviors have evolved, making data operationalization at scale a vital source of competitive advantage for life sciences. It is no longer enough to derive business strategy from data to ensure a competitive advantage. Executives now expect real-time updates from the market—and patients…

Read Now

Blog

Integrated Data + Hyper-local + Cross‑channel = Customer Engagement

Published October 1, 2024

The customer is changing The landscape around life sciences is more competitive than ever, with a shorter runway to success and market dynamics (payer, competition, etc.) that are indisputably changing the role and level of influence at a customer level. These changes are happening at a hyper-local level, not just at a homogenous national level. And it is this shift in control and influence locally that causes complexity for pharma to identify, prioritize, reach and engage key customers. Personalized, customer-centric…

Read Now

Blog

Early China Launch of PIASKY® in the Fight Against PNH​ 

Published September 25, 2024

In February 2024, the National Medical Products Administration (NMPA), China’s drug regulator, granted priority review approval to Roche’s PIASKY (crovalimab), an injectable C5 inhibitor for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH).  PNH is a rare genetic blood disorder in which the patient’s immune system attacks and destroys red blood cells and platelets. As the disease progresses, it can lead to severe complications that may become life-threatening. PNH is listed in the first edition of China’s rare disease catalog, with…

Read Now

Blog

Get Ready to Orchestrate a Better Customer Experience

Published September 17, 2024

What does orchestration mean for a brand? True orchestration considers a customer’s preferences before communicating with them. Learnings from past interactions and outcomes are used to identify the most relevant action to lead to a rewarding experience for both the customer and the brand. Orchestration can be defined as all channels learning from each other to create better “surround sound” for the customer. Orchestration for a brand means that you have a thoughtfully-built decision engine that can process historical customer…

Read Now

Blog

Can GenAI be Used to Improve Data Operations Efficiency?

Published September 12, 2024

The short answer is yes, by powering process automation with GenAI. It’s an approach that hasn’t received as much attention as other GenAI use cases within life sciences, but the results can be very powerful. To illustrate its power, we’ll examine a case study on identifying debarred healthcare professionals (HCPs). Why is it important to identify debarred HCPs? Pharmaceutical companies are mandated to cease all forms of engagement with debarred healthcare professionals (HCPs) in the U.S. Compliance entails identifying and…

Read Now

Blog

What Does “Good” Look Like in Customer Engagement? 

Published September 5, 2024

First, what does “omnichannel” mean in life sciences? Omnichannel is a customer-centric strategy leveraging technology, data and analytics across functions to optimize cross-channel engagement. So, why is it so hard to achieve effective customer engagement impact? There are some companies that have achieved intended outcomes when deploying “Omnichannel” and embarking on a “digital transformation” – but many have found it much harder than expected.  The challenges are driven by three areas of misperception: The simplistic view that omnichannel is a…

Read Now

Blog

IRA “Negotiations” Price Release: No Big Surprises, But Is the Industry Ready Today and for the Future?

Published August 16, 2024

Yesterday, CMS released the results of the first round of “negotiated” prices for the Inflation Reduction Act (IRA).1 The IRA is a historical landmark legislation for the pharmaceutical industry, and the results from these “negotiations” involving 10 of the top Medicare Part D drugs in terms of spend were eagerly awaited by many. Immediately, both the Biden Administration and the Harris-Walz campaign commented on the public savings that these “negotiations” have generated, claiming this as a “beginning”. “Medicare has reached…

Read Now

Blog

The Next Wave of Global AI Medical Devices: Innovation in Action

Published July 19, 2024

A recent bipartisan initiative by Senators Martin Heinrich, Mike Rounds, Marsha Blackburn and Todd Young urged the Centers for Medicare & Medicaid Services (CMS) to establish a formal payment pathway for algorithm-based health care services (ABHS). This move addresses the need for stable Medicare reimbursement for FDA-cleared AI and machine learning (ML) medical devices, which aid in diagnosis and treatment. This initiative underscores AI’s transformative potential in healthcare, prompting Deepak Sahu, Managing Director at Trinity Life Sciences, and Michelle (武丹…

Read Now

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

We would contact you in accordance with our Privacy Policy, which we invite you to visit for details about our data privacy practices, including, where appropriate, how you may access and correct the personal data we store or withdraw consent to the collection, use or disclosure of such information. We will not share your email address or personal information. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.